Following a fall surge of the COVID variant XEC, which led to flu-like symptoms and "wiping people out," there's a new ...

The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including ...

Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

In Australia, LP.8.1 has become the third most dominant strain in NSW (behind XEC and KP ... scientists fear it may be driving a new wave. Will COVID vaccines work against LP.8.1? Current COVID ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome ... As with its predecessor, the new drug candidate, Jun13296, targets a different ...

The White House has thrown its weight behind the lab leak theory, an idea that has divided intelligence agencies.

In Australia, LP.8.1 has become the third most dominant strain in NSW (behind XEC ... scientists fear it may be driving a new wave. Current COVID vaccines, including the most recently available ...